 | • レポートコード：QYR9ST04835 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、外分泌膵機能不全の世界市場について調査・分析し、外分泌膵機能不全の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（栄養管理、膵酵素補充療法（PERT）、ライフスタイル修正アプローチ）、用途別（栄養管理、膵酵素補充療法（PERT）、ライフスタイル修正アプローチ）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の外分泌膵機能不全市場動向 ・主要企業別マーケットシェア ・外分泌膵機能不全の種類別市場規模2014-2019 （栄養管理、膵酵素補充療法（PERT）、ライフスタイル修正アプローチ） ・外分泌膵機能不全の用途別市場規模2014-2019 （栄養管理、膵酵素補充療法（PERT）、ライフスタイル修正アプローチ） ・外分泌膵機能不全の北米市場：主要企業・種類別/用途別市場規模 ・外分泌膵機能不全のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・外分泌膵機能不全の中国市場：主要企業・種類別/用途別市場規模 ・外分泌膵機能不全の日本国内市場：主要企業・種類別/用途別市場規模 ・外分泌膵機能不全の東南アジア市場：主要企業・種類別/用途別市場規模 ・外分泌膵機能不全のインド市場：主要企業・種類別/用途別市場規模 ・外分泌膵機能不全の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Axcan Pharma、Aptalis Pharma、Eli Lilly、Cilian、Nordmark Arzneimittel、Laboratoires Mayoly Spindler） ・外分泌膵機能不全の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Exocrine pancreatic insufficiency (EPI) is an inability of proper digestion of food owing to insufficient levels of digestive enzymes from pancreas.EPI is commonly found in humans affected with Shwachman-Diamond Syndrome and cystic fibrosis. EPI is triggered by the progressive loss of pancreatic cells, which generates the digestive enzymes. EPI disturbs the normal growth, life expectancy and immune response. Diarrhoea, Steatorrhea, fatigue and weight loss are the key symptoms of EPI.
In 2018, the global Exocrine Pancreatic Insufficiency market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Exocrine Pancreatic Insufficiency status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Exocrine Pancreatic Insufficiency development in United States, Europe and China.
The key players covered in this study
Axcan Pharma
Aptalis Pharma
Eli Lilly
Cilian
Nordmark Arzneimittel
Laboratoires Mayoly Spindler
…
Market segment by Type, the product can be split into
Nutritional management
Pancreatic enzyme replacement therapy (PERT)
Life style modifications approach
Market segment by Application, split into
Nutritional management
Pancreatic enzyme replacement therapy (PERT)
Life style modifications approach
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Exocrine Pancreatic Insufficiency status, future forecast, growth opportunity, key market and key players.
To present the Exocrine Pancreatic Insufficiency development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Exocrine Pancreatic Insufficiency are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Exocrine Pancreatic Insufficiency Market Size Growth Rate by Type (2014-2025)
1.4.2 Nutritional management
1.4.3 Pancreatic enzyme replacement therapy (PERT)
1.4.4 Life style modifications approach
1.5 Market by Application
1.5.1 Global Exocrine Pancreatic Insufficiency Market Share by Application (2014-2025)
1.5.2 Nutritional management
1.5.3 Pancreatic enzyme replacement therapy (PERT)
1.5.4 Life style modifications approach
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Exocrine Pancreatic Insufficiency Market Size
2.2 Exocrine Pancreatic Insufficiency Growth Trends by Regions
2.2.1 Exocrine Pancreatic Insufficiency Market Size by Regions (2014-2025)
2.2.2 Exocrine Pancreatic Insufficiency Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Exocrine Pancreatic Insufficiency Market Size by Manufacturers
3.1.1 Global Exocrine Pancreatic Insufficiency Revenue by Manufacturers (2014-2019)
3.1.2 Global Exocrine Pancreatic Insufficiency Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Exocrine Pancreatic Insufficiency Market Concentration Ratio (CR5 and HHI)
3.2 Exocrine Pancreatic Insufficiency Key Players Head office and Area Served
3.3 Key Players Exocrine Pancreatic Insufficiency Product/Solution/Service
3.4 Date of Enter into Exocrine Pancreatic Insufficiency Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Exocrine Pancreatic Insufficiency Market Size by Type (2014-2019)
4.2 Global Exocrine Pancreatic Insufficiency Market Size by Application (2014-2019)
5 United States
5.1 United States Exocrine Pancreatic Insufficiency Market Size (2014-2019)
5.2 Exocrine Pancreatic Insufficiency Key Players in United States
5.3 United States Exocrine Pancreatic Insufficiency Market Size by Type
5.4 United States Exocrine Pancreatic Insufficiency Market Size by Application
6 Europe
6.1 Europe Exocrine Pancreatic Insufficiency Market Size (2014-2019)
6.2 Exocrine Pancreatic Insufficiency Key Players in Europe
6.3 Europe Exocrine Pancreatic Insufficiency Market Size by Type
6.4 Europe Exocrine Pancreatic Insufficiency Market Size by Application
7 China
7.1 China Exocrine Pancreatic Insufficiency Market Size (2014-2019)
7.2 Exocrine Pancreatic Insufficiency Key Players in China
7.3 China Exocrine Pancreatic Insufficiency Market Size by Type
7.4 China Exocrine Pancreatic Insufficiency Market Size by Application
8 Japan
8.1 Japan Exocrine Pancreatic Insufficiency Market Size (2014-2019)
8.2 Exocrine Pancreatic Insufficiency Key Players in Japan
8.3 Japan Exocrine Pancreatic Insufficiency Market Size by Type
8.4 Japan Exocrine Pancreatic Insufficiency Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Exocrine Pancreatic Insufficiency Market Size (2014-2019)
9.2 Exocrine Pancreatic Insufficiency Key Players in Southeast Asia
9.3 Southeast Asia Exocrine Pancreatic Insufficiency Market Size by Type
9.4 Southeast Asia Exocrine Pancreatic Insufficiency Market Size by Application
10 India
10.1 India Exocrine Pancreatic Insufficiency Market Size (2014-2019)
10.2 Exocrine Pancreatic Insufficiency Key Players in India
10.3 India Exocrine Pancreatic Insufficiency Market Size by Type
10.4 India Exocrine Pancreatic Insufficiency Market Size by Application
11 Central & South America
11.1 Central & South America Exocrine Pancreatic Insufficiency Market Size (2014-2019)
11.2 Exocrine Pancreatic Insufficiency Key Players in Central & South America
11.3 Central & South America Exocrine Pancreatic Insufficiency Market Size by Type
11.4 Central & South America Exocrine Pancreatic Insufficiency Market Size by Application
12 International Players Profiles
12.1 Axcan Pharma
12.1.1 Axcan Pharma Company Details
12.1.2 Company Description and Business Overview
12.1.3 Exocrine Pancreatic Insufficiency Introduction
12.1.4 Axcan Pharma Revenue in Exocrine Pancreatic Insufficiency Business (2014-2019)
12.1.5 Axcan Pharma Recent Development
12.2 Aptalis Pharma
12.2.1 Aptalis Pharma Company Details
12.2.2 Company Description and Business Overview
12.2.3 Exocrine Pancreatic Insufficiency Introduction
12.2.4 Aptalis Pharma Revenue in Exocrine Pancreatic Insufficiency Business (2014-2019)
12.2.5 Aptalis Pharma Recent Development
12.3 Eli Lilly
12.3.1 Eli Lilly Company Details
12.3.2 Company Description and Business Overview
12.3.3 Exocrine Pancreatic Insufficiency Introduction
12.3.4 Eli Lilly Revenue in Exocrine Pancreatic Insufficiency Business (2014-2019)
12.3.5 Eli Lilly Recent Development
12.4 Cilian
12.4.1 Cilian Company Details
12.4.2 Company Description and Business Overview
12.4.3 Exocrine Pancreatic Insufficiency Introduction
12.4.4 Cilian Revenue in Exocrine Pancreatic Insufficiency Business (2014-2019)
12.4.5 Cilian Recent Development
12.5 Nordmark Arzneimittel
12.5.1 Nordmark Arzneimittel Company Details
12.5.2 Company Description and Business Overview
12.5.3 Exocrine Pancreatic Insufficiency Introduction
12.5.4 Nordmark Arzneimittel Revenue in Exocrine Pancreatic Insufficiency Business (2014-2019)
12.5.5 Nordmark Arzneimittel Recent Development
12.6 Laboratoires Mayoly Spindler
12.6.1 Laboratoires Mayoly Spindler Company Details
12.6.2 Company Description and Business Overview
12.6.3 Exocrine Pancreatic Insufficiency Introduction
12.6.4 Laboratoires Mayoly Spindler Revenue in Exocrine Pancreatic Insufficiency Business (2014-2019)
12.6.5 Laboratoires Mayoly Spindler Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Exocrine Pancreatic Insufficiency Key Market Segments
Table Key Players Exocrine Pancreatic Insufficiency Covered
Table Global Exocrine Pancreatic Insufficiency Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Exocrine Pancreatic Insufficiency Market Size Market Share by Type 2014-2025
Figure Nutritional management Figures
Table Key Players of Nutritional management
Figure Pancreatic enzyme replacement therapy (PERT) Figures
Table Key Players of Pancreatic enzyme replacement therapy (PERT)
Figure Life style modifications approach Figures
Table Key Players of Life style modifications approach
Table Global Exocrine Pancreatic Insufficiency Market Size Growth by Application 2014-2025 (Million US$)
Figure Nutritional management Case Studies
Figure Pancreatic enzyme replacement therapy (PERT) Case Studies
Figure Life style modifications approach Case Studies
Figure Exocrine Pancreatic Insufficiency Report Years Considered
Table Global Exocrine Pancreatic Insufficiency Market Size 2014-2025 (Million US$)
Figure Global Exocrine Pancreatic Insufficiency Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Exocrine Pancreatic Insufficiency Market Size by Regions 2014-2025 (Million US$)
Table Global Exocrine Pancreatic Insufficiency Market Size by Regions 2014-2019 (Million US$)
Table Global Exocrine Pancreatic Insufficiency Market Share by Regions 2014-2019
Figure Global Exocrine Pancreatic Insufficiency Market Share by Regions 2014-2019
Figure Global Exocrine Pancreatic Insufficiency Market Share by Regions 2019
Table Market Top Trends
Table Global Exocrine Pancreatic Insufficiency Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Exocrine Pancreatic Insufficiency Market Share by Manufacturers (2014-2019)
Figure Global Exocrine Pancreatic Insufficiency Market Share by Manufacturers in 2018
Table Global Exocrine Pancreatic Insufficiency Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Exocrine Pancreatic Insufficiency Product/Solution/Service
Table Date of Enter into Exocrine Pancreatic Insufficiency Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Exocrine Pancreatic Insufficiency Market Size by Type (2014-2019) (Million US$)
Table Global Exocrine Pancreatic Insufficiency Market Size Share by Type (2014-2019)
Figure Global Exocrine Pancreatic Insufficiency Market Size Market Share by Type (2014-2019)
Table Global Exocrine Pancreatic Insufficiency Market Size by Application (2014-2019) (Million US$)
Table Global Exocrine Pancreatic Insufficiency Market Size Share by Application (2014-2019)
Figure Global Exocrine Pancreatic Insufficiency Market Size Market Share by Application (2014-2019)
Figure Global Exocrine Pancreatic Insufficiency Revenue Market Share by Application in 2018
Figure United States Exocrine Pancreatic Insufficiency Market Size 2014-2019 (Million US$)
Table United States Key Players Exocrine Pancreatic Insufficiency Revenue (2018-2019) (Million US$)
Table United States Key Players Exocrine Pancreatic Insufficiency Market Share (2018-2019)
Table United States Exocrine Pancreatic Insufficiency Market Size by Type (2014-2019) (Million US$)
Table United States Exocrine Pancreatic Insufficiency Market Share by Type (2014-2019)
Table United States Exocrine Pancreatic Insufficiency Market Size by Application (2014-2019) (Million US$)
Table United States Exocrine Pancreatic Insufficiency Market Share by Application (2014-2019)
Figure Europe Exocrine Pancreatic Insufficiency Market Size 2014-2019 (Million US$)
Table Europe Key Players Exocrine Pancreatic Insufficiency Revenue (2018-2019) (Million US$)
Table Europe Key Players Exocrine Pancreatic Insufficiency Market Share (2018-2019)
Table Europe Exocrine Pancreatic Insufficiency Market Size by Type (2014-2019) (Million US$)
Table Europe Exocrine Pancreatic Insufficiency Market Share by Type (2014-2019)
Table Europe Exocrine Pancreatic Insufficiency Market Size by Application (2014-2019) (Million US$)
Table Europe Exocrine Pancreatic Insufficiency Market Share by Application (2014-2019)
Figure China Exocrine Pancreatic Insufficiency Market Size 2014-2019 (Million US$)
Table China Key Players Exocrine Pancreatic Insufficiency Revenue (2018-2019) (Million US$)
Table China Key Players Exocrine Pancreatic Insufficiency Market Share (2018-2019)
Table China Exocrine Pancreatic Insufficiency Market Size by Type (2014-20189) (Million US$)
Table China Exocrine Pancreatic Insufficiency Market Share by Type (2014-2019)
Table China Exocrine Pancreatic Insufficiency Market Size by Application (2014-2019) (Million US$)
Table China Exocrine Pancreatic Insufficiency Market Share by Application (2014-2019)
Figure Japan Exocrine Pancreatic Insufficiency Market Size 2014-2019 (Million US$)
Table Japan Key Players Exocrine Pancreatic Insufficiency Revenue (2018-2019) (Million US$)
Table Japan Key Players Exocrine Pancreatic Insufficiency Market Share (2018-2019)
Table Japan Exocrine Pancreatic Insufficiency Market Size by Type (2014-2019) (Million US$)
Table Japan Exocrine Pancreatic Insufficiency Market Share by Type (2014-2019)
Table Japan Exocrine Pancreatic Insufficiency Market Size by Application (2014-2019) (Million US$)
Table Japan Exocrine Pancreatic Insufficiency Market Share by Application (2014-2019)
Figure Southeast Asia Exocrine Pancreatic Insufficiency Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Exocrine Pancreatic Insufficiency Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Exocrine Pancreatic Insufficiency Market Share (2018-2019)
Table Southeast Asia Exocrine Pancreatic Insufficiency Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Exocrine Pancreatic Insufficiency Market Share by Type (2014-2019)
Table Southeast Asia Exocrine Pancreatic Insufficiency Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Exocrine Pancreatic Insufficiency Market Share by Application (2014-2019)
Figure India Exocrine Pancreatic Insufficiency Market Size 2014-2019 (Million US$)
Table India Key Players Exocrine Pancreatic Insufficiency Revenue (2018-2019) (Million US$)
Table India Key Players Exocrine Pancreatic Insufficiency Market Share (2018-2019)
Table India Exocrine Pancreatic Insufficiency Market Size by Type (2014-2019) (Million US$)
Table India Exocrine Pancreatic Insufficiency Market Share by Type (2014-2019)
Table India Exocrine Pancreatic Insufficiency Market Size by Application (2014-2019) (Million US$)
Table India Exocrine Pancreatic Insufficiency Market Share by Application (2014-2019)
Figure Central & South America Exocrine Pancreatic Insufficiency Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Exocrine Pancreatic Insufficiency Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Exocrine Pancreatic Insufficiency Market Share (2018-2019)
Table Central & South America Exocrine Pancreatic Insufficiency Market Size by Type (2014-2019) (Million US$)
Table Central & South America Exocrine Pancreatic Insufficiency Market Share by Type (2014-2019)
Table Central & South America Exocrine Pancreatic Insufficiency Market Size by Application (2014-2019) (Million US$)
Table Central & South America Exocrine Pancreatic Insufficiency Market Share by Application (2014-2019)
Table Axcan Pharma Company Details
Table Axcan Pharma Revenue in Exocrine Pancreatic Insufficiency Business (2014-2019) (Million US$)
Figure Axcan Pharma Revenue Growth Rate in Exocrine Pancreatic Insufficiency Business (2014-2019)
Table Axcan Pharma Recent Development
Table Aptalis Pharma Company Details
Table Aptalis Pharma Revenue in Exocrine Pancreatic Insufficiency Business (2014-2019)(Million US$)
Figure Aptalis Pharma Revenue Growth Rate in Exocrine Pancreatic Insufficiency Business (2014-2019)
Table Aptalis Pharma Recent Development
Table Eli Lilly Company Details
Table Eli Lilly Revenue in Exocrine Pancreatic Insufficiency Business (2014-2019)(Million US$)
Figure Eli Lilly Revenue Growth Rate in Exocrine Pancreatic Insufficiency Business (2014-2019)
Table Eli Lilly Recent Development
Table Cilian Company Details
Table Cilian Revenue in Exocrine Pancreatic Insufficiency Business (2014-2019)(Million US$)
Figure Cilian Revenue Growth Rate in Exocrine Pancreatic Insufficiency Business (2014-2019)
Table Cilian Recent Development
Table Nordmark Arzneimittel Company Details
Table Nordmark Arzneimittel Revenue in Exocrine Pancreatic Insufficiency Business (2014-2019)(Million US$)
Figure Nordmark Arzneimittel Revenue Growth Rate in Exocrine Pancreatic Insufficiency Business (2014-2019)
Table Nordmark Arzneimittel Recent Development
Table Laboratoires Mayoly Spindler Company Details
Table Laboratoires Mayoly Spindler Revenue in Exocrine Pancreatic Insufficiency Business (2014-2019)(Million US$)
Figure Laboratoires Mayoly Spindler Revenue Growth Rate in Exocrine Pancreatic Insufficiency Business (2014-2019)
Table Laboratoires Mayoly Spindler Recent Development
Table Global Exocrine Pancreatic Insufficiency Market Size by Regions (Million US$) 2019-2025
Figure Global Exocrine Pancreatic Insufficiency Market Size Share by Regions (2019-2025)
Figure Global Exocrine Pancreatic Insufficiency Market Size Share by Regions in 2025
Figure United States Exocrine Pancreatic Insufficiency Market Size Forecast (2019-2025)(Million USD)
Figure Europe Exocrine Pancreatic Insufficiency Market Size Forecast (2019-2025)(Million USD)
Figure China Exocrine Pancreatic Insufficiency Market Size Forecast (2019-2025)(Million USD)
Figure Japan Exocrine Pancreatic Insufficiency Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Exocrine Pancreatic Insufficiency Market Size Forecast (2019-2025)(Million USD)
Figure India Exocrine Pancreatic Insufficiency Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Exocrine Pancreatic Insufficiency Market Size Forecast (2019-2025)(Million USD)
Table Global Exocrine Pancreatic Insufficiency Market Size by Product (2019-2025) (Million US$)
Figure Global Exocrine Pancreatic Insufficiency Market Size by Product (2019-2025)
Figure Global Exocrine Pancreatic Insufficiency Market Size by Product in 2025
Table Global Exocrine Pancreatic Insufficiency Market Size by Application (2019-2025) (Million US$)
Figure Global Exocrine Pancreatic Insufficiency Market Size by Application (2019-2025)
Figure Global Exocrine Pancreatic Insufficiency Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
膵臓癌治療の世界市場：市場規模・現状・予測 Pancreatic cancer therapy is recommended by clinicians for early detection of cancer. Pancreatic cancer generally diagnosed at a later stage, since the symptoms are not easily detected or diagnosed. Factors such as, chronic inflammation of the pancreas (pancreatitis), diabetes, smoking, and obesity …- 膵臓癌治療の世界市場：インサイト・予測 Pancreatic cancer arises when cells in the pancreas, a glandular organ behind the stomach, begin to multiply out of control and form a mass. These cancerous cells have the ability to invade other parts of the body.The global Pancreatic Cancer Treatment market is valued at xx million US$ in 2018 and …
- 膵臓ステントの世界市場：インサイト・予測 Pancreatic endotherapy has been used progressively for the treatment of a range of pancreatic disorders such as drainage of pseudocysts, chronic pancreatitis, recurrent acute pancreatitis, or disruptions, pancreatic duct leaks, and for the prevention of pancreatitis post ERCP (endoscopic retrograde …
- 世界の膵臓及び胆管ステント市場：動向・競争分析 Pancreatic and Biliary stents are tubular devices made of plastic or metal used primarily to establish patency of an obstructed bile or pancreatic duct.The Pancreatic and Biliary Stent market was valued at xx Million US$ in 2018 and is projected to reach xx Million US$ by 2025, at a CAGR of xx% duri…
- 世界の膵臓及び胆管ステント市場：動向・競争分析 Pancreatic and Biliary stents are tubular devices made of plastic or metal used primarily to establish patency of an obstructed bile or pancreatic duct.The Pancreatic and Biliary Stent market was valued at xx Million US$ in 2018 and is projected to reach xx Million US$ by 2025, at a CAGR of xx% duri…